BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant-Reference-Cited by-同舟云学术

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant

Published:2020-04-16 Issue:8 Volume:16 Page:1989-1996
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Kaushik Deepender¹,Dhingra Simran¹,Patil Madhuri T.²,Piplani Sakshi³⁴,Khanna Varun³⁴,Honda-Okubo Yoshikazu³⁴,Li Lei³⁴,Fung Johnson³,Sakala Isaac G.³⁴,Salunke Deepak B.¹⁵^ORCID,Petrovsky Nikolai³⁴^ORCID

Affiliation:

1. Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, India

2. Department of Chemistry, Mehr Chand Mahajan DAV College for Women, Chandigarh, India

3. Vaxine Pty Ltd, Warradale, Australia

4. College of Medicine and Public Health, Flinders University, Adelaide, Australia

5. National Interdisciplinary Centre of Vaccine, Immunotherapeutics and Antimicrobials (NICOVIA), Panjab University, Chandigarh, India

Funder

National Institute of Allergy and Infectious Diseases

SPARC

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1710409

Reference41 articles.

1. Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs

2. Potential adjuvantic properties of innate immune stimuli

3. Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants

4. Mechanisms of Action of Adjuvants

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of the Adjuvant Potential of Imidazoquinoline-Based TLR7/8 Agonists via Alum Adsorption;ACS Medicinal Chemistry Letters;2024-07-22

2. Design and Synthesis of Polyphenolic Imidazo[4,5-c]quinoline Derivatives to Modulate Toll Like Receptor-7 Agonistic Activity and Adjuvanticity;ACS Pharmacology & Translational Science;2024-06-12

3. Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection;International Journal of Molecular Sciences;2024-05-29

4. Structure–Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist;Journal of Medicinal Chemistry;2024-05-14

5. Structure-activity relationship in NOD2 agonistic muramyl dipeptides;European Journal of Medicinal Chemistry;2024-05